Ombitasvir (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ombitasvir" in English language version.

refsWebsite

Global rank English rank

4web.archive.org

1^st place

1^st place

low place

low place

447^th place

338^th place

3,558^th place

2,403^rd place

2^nd place

2^nd place

4^th place

4^th place

doi.org

Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, et al. (April 2014). "Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin" (PDF). The New England Journal of Medicine. 370 (17): 1594–603. doi:10.1056/NEJMoa1315722. PMID 24720703.

fda.gov

"FDA approves Viekira Pak to treat hepatitis C". Food and Drug Administration. December 19, 2014. Archived from the original on December 25, 2014.
"FDA approves Technivie for treatment of chronic hepatitis C genotype 4". Food and Drug Administration. July 24, 2015. Archived from the original on July 27, 2015.

nih.gov

pubmed.ncbi.nlm.nih.gov

Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, et al. (April 2014). "Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin" (PDF). The New England Journal of Medicine. 370 (17): 1594–603. doi:10.1056/NEJMoa1315722. PMID 24720703.

rxabbvie.com

"VIEKIRA PAK™ (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets), for Oral Use. Full Prescribing Information" (PDF). AbbVie Inc., North Chicago, IL 60064. Archived from the original (PDF) on 2 May 2019. Retrieved 30 July 2015.
"TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) Tablets, for Oral Use. Full Prescribing Information" (PDF). AbbVie Inc., North Chicago, IL 60064. Archived from the original (PDF) on 19 January 2019. Retrieved 28 July 2015.

uq.edu.au

espace.library.uq.edu.au

Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, et al. (April 2014). "Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin" (PDF). The New England Journal of Medicine. 370 (17): 1594–603. doi:10.1056/NEJMoa1315722. PMID 24720703.

web.archive.org

"VIEKIRA PAK™ (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets), for Oral Use. Full Prescribing Information" (PDF). AbbVie Inc., North Chicago, IL 60064. Archived from the original (PDF) on 2 May 2019. Retrieved 30 July 2015.
"FDA approves Viekira Pak to treat hepatitis C". Food and Drug Administration. December 19, 2014. Archived from the original on December 25, 2014.
"TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) Tablets, for Oral Use. Full Prescribing Information" (PDF). AbbVie Inc., North Chicago, IL 60064. Archived from the original (PDF) on 19 January 2019. Retrieved 28 July 2015.
"FDA approves Technivie for treatment of chronic hepatitis C genotype 4". Food and Drug Administration. July 24, 2015. Archived from the original on July 27, 2015.